Captisol® is Ligand Pharmaceuticals' patent-protected, solvent free, all-aqueous modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, at the University of Kansas’ Higuchi Biosciences Center.
Captisol® is currently in 16 approved products and can help you get your product to market and to the patients you serve. We've helped over 13 million patients in 120 countries optimize their drug products.